Nevada Cancer Institute opens Las Vegas center
The Nevada Cancer Institute has opened its flagship research and care center in Las Vegas.
The Nevada Cancer Institute has opened its flagship research and care center in Las Vegas. The Institute said the facility and staff will bring state-of-the-art, personalized research and care to residents of Nevada and the southeast United States on an outpatient basis.
"The power of the facility is in what and how it will facilitate leading-edge research, invention, and innovation among Nevada Cancer Institute faculty," said Nicholas J. Vogelzang, MD, the Institute's director.
The center and staff provide multidisciplinary services, including clinical trials, medical oncology, radiation oncology, pathology and imaging, and quality-of-life services.
Dr. Vogelzang, a recognized expert in genitourinary malignancies, joined the Nevada Cancer Institute last January. John F. Ward, MD, joined the Institute as the chief of its department of urologic oncology in July 2005.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
